Cytopoint 30mg - Pack of 2 Vials

Description

Allergic dermatitis describes inflammation caused by an allergic reaction, but the trigger is not the same for every dog. Possible causes include flea allergy dermatitis, food hypersensitivity, contact reactions and environmental allergens such as pollens, mould spores or house dust mites. Canine atopic dermatitis is usually a chronic, relapsing inflammatory condition associated with sensitivity to environmental allergens and a weakened skin barrier. Some dogs flare seasonally, while others remain itchy throughout the year. The pattern may change as the disease progresses or new allergens become relevant. Commonly affected sites include the paws, face, ears, armpits, groin and abdomen. Owners may notice erythema, which means redness, recurrent otitis externa, saliva staining, papules, scabs, greasy skin, unpleasant odour or repeated episodes of bacterial or Malassezia yeast overgrowth. Cytopoint 30mg helps reduce the itch that drives licking, chewing and scratching, giving damaged skin a better opportunity to recover. It does not remove an allergen or cure atopic dermatitis, so veterinary investigation remains important, especially when symptoms are severe, return frequently or occur alongside ear disease or infection.

Cytopoint 30mg works differently from corticosteroids and conventional immunosuppressive medicines. Lokivetmab is a caninised monoclonal antibody, meaning it is designed to act like an antibody within the canine immune system. It specifically targets interleukin-31, usually shortened to IL-31, which is an important cytokine involved in transmitting the sensation of itch in many dogs with allergic skin disease. By binding to IL-31, Cytopoint for Dogs prevents this messenger from attaching to its co-receptor and interrupts the cell signalling that contributes to pruritus. This targeted action can relieve atopic dermatitis-related itching and provide anti-inflammatory activity without Cytopoint 30mg being a steroid. Because the mechanism is highly specific, not every itchy dog responds equally. In a laboratory model, an effect on itching was demonstrated by the first assessment point eight hours after administration, although the speed and degree of improvement vary between individual dogs. Some dogs settle quickly, while others need more time or further treatment for infection, parasites or other contributors to their discomfort.

Cytopoint 30mg is administered as a subcutaneous injection, which means it is placed beneath the skin. If the first injection produces no response or only limited improvement after one month, some dogs may respond better after a second monthly dose. When there is still no better response following that second dose, the vet should reassess the diagnosis and consider another approach. Cytopoint for Dogs must not be used in dogs weighing less than 3kg.

Good control of allergic skin disease usually depends on more than stopping the itch. While Cytopoint 30mg can help break the itch-scratch cycle, the underlying trigger should be investigated wherever possible. This may involve reliable flea control, examination for mites, a carefully managed elimination diet, review of seasonal patterns or assessment for contact irritants. Complicating bacterial, fungal and parasitic conditions also require attention, because an infection can keep the skin inflamed even when IL-31 signalling has been reduced. Dogs should be monitored for bacterial skin infection, particularly during the first weeks of treatment. Improvement in scratching does not always mean infection has resolved. Signs such as pustules, spreading redness, crusting, discharge, increasing odour, painful skin or a sudden return of intense scratching deserve veterinary advice. Depending on the findings, Cytopoint 30mg may form one part of a plan that also includes antimicrobial treatment, medicated shampoo, ear care, barrier-focused skincare or allergen avoidance. Regular reviews allow treatment to be adjusted to the dog’s response rather than continued automatically.

What is 30mg Cytopoint used for in dogs?
30mg Cytopoint is used to help control allergic itching in dogs, particularly itch linked to atopic dermatitis. It is prescribed by a vet as part of an individual treatment plan and is intended to reduce the urge to scratch, chew, lick and rub irritated skin.

How does 30mg Cytopoint work?
30mg Cytopoint works by targeting interleukin-31, a protein involved in sending itch signals in allergic dogs. It contains lokivetmab, a monoclonal antibody that binds to this itch messenger, helping reduce pruritus in a focused way rather than using a broad anti-inflammatory effect.

Is Cytopoint a steroid?
No, 30mg Cytopoint is not a steroid. It is a monoclonal antibody treatment designed to target one of the key itch pathways in dogs. Many owners and vets value this because it offers a different clinical approach to managing allergic itch.

How quickly can 30mg Cytopoint start working?
Many dogs show improvement fairly quickly after receiving Cytopoint, although the exact response time can vary. Some become less itchy within a short period, while others improve more gradually as the skin begins to settle and the itch-scratch cycle starts to break.

How long does Cytopoint last?
The effect of 30mg Cytopoint can vary between dogs, which is why your vet will advise on timing for repeat treatment. Some dogs remain comfortable for several weeks, while others may need closer monitoring and a dosing schedule that reflects their own pattern of allergic flare-ups.